Posts Tagged ‘diabetes’

The nature of liver disease is shifting in the U.S. Over the last three decades, hepatitis C has dropped by nearly half. But over that same time, we’ve seen more liver disease due to obesity and diabetes. In fact, NAFLD (non-alcoholic fatty liver disease) has grown in almost perfect synchrony with obesity and type 2 […]

Food and beverage marketers have one very clear mission. Encourage people to drink and eat more. Thus, they innovate, they formulate, and they communicate. And it all advances a singular purpose – sell more. Superfood, healthy food, food fads – they’re all part of the marketing machine. More than ever, that machine relies on academic […]

If the recent news of diabetes incidence going down seemed like great news, let’s remember there’s a flip side to that. In youth, type 2 diabetes is still rising. At the American Diabetes Association (ADA) scientific meeting, researchers spelled out the implication. Youth-onset diabetes (type 2) is harsh. Complications come faster and they hit harder. […]

Some of the most discussed news coming from the American Diabetes Association Scientific Sessions in San Francisco is all about the PIONEER studies of oral semaglutide. This drug is presently under review at FDA for type 2 diabetes. Interest is keen because it will be the first of its class that doesn’t require an injection. […]

It’s been a wild ride. Almost 40 years ago, David Jenkins published the first paper to propose that the glycemic index of foods might be an important measure of nutrition quality. Back then, dietary guidance pointed to a low-fat panacea. Research continued quietly on the glycemic index. The pendulum swung from fear of fats to […]

This is now unmistakeable. And it seems like a rare piece of good news. For the first time in decades, diabetes incidence is going down. The real question is, why? And the honest answer is nobody knows. A Trend That Started in 2008 Stephen Benoit and colleagues from CDC analyzed U.S. trends in the diabetes […]

Today we’re at the WHO for the WHA learning all about NCDs and UHC. Alphabet soup for lunch. Obesity? It was hiding behind the chia seeds at the breakfast buffet. Noncommunicable diseases (NCDs) and universal health coverage (UHC) are big priorities at the 72nd World Health Assembly (WHA) in Geneva today. But within the global […]

My, how things have changed. Barely more than a decade ago, the dominant drugs for type 2 diabetes caused weight gain. Most big pharma companies were cutting obesity research. Eli Lilly and Sanofi were riding high in diabetes care and turning up their noses at obesity. But now the tables have turned. Sanofi’s diabetes business […]

Tomorrow is tax day in the U.S. Maybe you have it all squared away or maybe it’s not a worry for you. Whatever the case may be, it’s worth taking this moment to think about a tax we could all live without. Writing in Diabetes Care, Timothy Dall tells us that we’re all paying what […]

Why does bariatric surgery have such a profound effect on diabetes? It’s more than you might expect simply from the effects on weight. A large portion of patients with diabetes and obesity have remissions after surgery. Even before they lose much weight. New research in Cell Reports this week points to GLP-1 secretion as a […]